Lauro A, Boselli C, Bufalari A, Fabbri B, Cirocchi R, Fabbri C, Bisacci R, Giustozzi G, Moggi L
Dipartimento di Scienze Chirurgiche, Università degli Studi di Perugia.
Ann Ital Chir. 1999 Jul-Aug;70(4):561-7.
Considering that laparoscopic procedure is associated with increased resistance to lower-limb venous return and subsequent stasis, with possible implications in terms of thromboembolic complications, the aim of our study was to investigate prospectively the coagulative-fibrinolytic profile, in laparoscopic and open cholecystectomy, in patients randomly alloted to receive or not preoperative heparin.
We prospectively analyzed 36 patients (20 laparoscopic and 16 open) and we randomly divided the patients in two groups: Group-A (28 patients--16 laparoscopic and 12 open) didn't take any preoperative thromboprophylaxis, Group-B (8 patients--4 laparoscopic and 4 open) took preoperative subcutaneous heparin. We took blood venous samples before surgery, at time 0 and + 30 min., at the end and 1 and 24 hours postoperatively. The following parameters were assessed: prothrombin time, partial thromboplastin time, fibrinogen and D-dimer. We statistically analyzed the differences by ANOVA test.
In Group A, fibrinogen and D-dimer were significantly higher (p < 0.0001 and p = 0.0266) in open group as compared with laparoscopic one and we observed significant time-depending changes of fibrinogen's concentration (p = 0.0168). In Group B we obtained a higher fibrinogen's value in laparoscopic group than in conventional one, with a significant difference (p = 0.0283); also, the sampling-time affected the result in a very significant meaning (p = 0.0041). Comparing fibrinogen levels between Groups A and B, we observed lower values in heparin-treated group than in the other one (p < 0.0001), while in laparoscopic surgery there was not a significant difference between two groups of treatment.
Our preliminary data suggest that, perioperatively (besides a smaller laparoscopic acute-phase response) the coagulative-fibrinolytic changes are lower in laparoscopic cholecystectomy than in open one and heparin treatment significantly reduces these changes in open surgery but doesn't seem to affect laparoscopic group. Our results seem to show another possible advantage of the laparoscopic surgical procedures over the traditional ones.
鉴于腹腔镜手术会增加下肢静脉回流阻力并导致随后的血液淤滞,这可能会引发血栓栓塞并发症,我们研究的目的是前瞻性地调查在接受或不接受术前肝素治疗的患者中,腹腔镜胆囊切除术和开腹胆囊切除术时的凝血 - 纤溶情况。
我们前瞻性地分析了36例患者(20例行腹腔镜手术,16例行开腹手术),并将患者随机分为两组:A组(28例患者 - 16例行腹腔镜手术,12例行开腹手术)未进行任何术前血栓预防;B组(8例患者 - 4例行腹腔镜手术,4例行开腹手术)接受术前皮下注射肝素。我们在手术前、0时和 +30分钟、手术结束时以及术后1小时和24小时采集静脉血样本。评估以下参数:凝血酶原时间、活化部分凝血活酶时间、纤维蛋白原和D - 二聚体。我们通过方差分析对差异进行统计学分析。
在A组中,开腹组的纤维蛋白原和D - 二聚体显著高于腹腔镜组(p < 0.0001和p = 0.0266),并且我们观察到纤维蛋白原浓度有显著的时间依赖性变化(p = 0.0168)。在B组中,腹腔镜组的纤维蛋白原值高于传统组,差异有统计学意义(p = 0.0283);此外,采样时间对结果有非常显著的影响(p = 0.0041)。比较A组和B组的纤维蛋白原水平,我们观察到肝素治疗组的值低于另一组(p < 0.0001),而在腹腔镜手术中,两组治疗之间没有显著差异。
我们的初步数据表明,围手术期(除了较小的腹腔镜急性期反应外),腹腔镜胆囊切除术的凝血 - 纤溶变化低于开腹手术,肝素治疗可显著降低开腹手术中的这些变化,但似乎对腹腔镜组没有影响。我们的结果似乎显示了腹腔镜手术相对于传统手术的另一个可能优势。